Alchemist Limited

ALCHEM

INE964B01033

Diversified Chemicals

Market Closed - Bombay S.E. Other stock markets 03:30:55 13/12/2021 pm IST			5-day change	1st Jan Change
3.01 ^INR	+4.88%		-.--%	-.--%

2021	Pombe Biosciences LLP cancelled the acquisition of Pharma Division of Alchemist Limited.	CI
2020	Alchemist Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	CI

Alchemist Limited Appoints Hemant Kumar Mangal as Company Secretary and Compliance Officer with Effect from April 2, 2018

April 02, 2018 at 03:45 pm IST

Alchemist Limited appointed Hemant Kumar Mangal as company secretary and compliance officer with effect from April 2, 2018 by the board of directors at the board meeting held on April 2, 2018.

Latest news about Alchemist Limited

Pombe Biosciences LLP cancelled the acquisition of Pharma Division of Alchemist Limited.	12/21/12	CI
Alchemist Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/20/12	CI
Alchemist Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	30/20/30	CI
Alchemist Limited Provides Update on Restarting the Operations	18/20/18	CI
Alchemist Limited Suspends Operations At All Their Offices from March 23, 2020 to March 31, 2020	23/20/23	CI
Alchemist Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	16/20/16	CI
Alchemist Limited Announces Executive Changes	13/20/13	CI
Pombe Biosciences LLP agreed to acquire Pharma Division of Alchemist Limited for INR 10 million.	12/20/12	CI
Alchemist Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	11/19/11	CI
Alchemist Limited Appoints Charandeep Singh Jolly as Non-Executive Director	01/19/01	CI
Alchemist Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	12/19/12	CI
Alchemist Limited Announces Resignation of Dinesh Kumar as Chief Financial Officer, Effective from July 02, 2019	02/19/02	CI
Alchemist Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Standalone and Consolidated Earnings Results for the Year Ended March 31, 2019	27/19/27	CI
Alchemist Limited Announces Management Changes	15/19/15	CI
Alchemist Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	13/19/13	CI
Alchemist Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	15/18/15	CI
Alchemist Limited Announces Unaudited Standalone Earnings Results for the Quarter Ended June 30, 2018	10/18/10	CI
Alchemist Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Standalone and Consolidated Earnings Results for the Year Ended March 31, 2018	21/18/21	CI
Alchemist Limited Announces Resignation of Vinay Singh as Company Secretary and Compliance Officer with Effect from March 9, 2018	02/18/02	CI
Alchemist Limited Appoints Hemant Kumar Mangal as Company Secretary and Compliance Officer with Effect from April 2, 2018	02/18/02	CI
Alchemist Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	14/18/14	CI
Alchemist Limited Announces Executive Changes	21/17/21	CI
Alchemist Limited Reports Unaudited Consolidated Earnings Results for the second Quarter and six Months Ended September 30, 2017	09/17/09	CI
Alchemist Limited Appoints Bikram Bhattacharya as an Additional Director	15/17/15	CI
Alchemist Limited Announces Resignation of Pavan Kumar Verma as Whole Time Director of the Company, Effective September 15, 2017	15/17/15	CI

Alchemist Limited is an India-based company that is engaged in the business of agriculture and allied activities consisting of floriculture and manufacturing of wire mesh for the poultry industry and trading of chemicals and pharmaceutical formulations. The Company's segments include Agri Business and Pharma, Chemical & Minerals. The Company's portfolio covers therapy areas, such as immune enhancer, antibacterial, gastrointestinal, pain reliever, anti-allergic, anti-cold, steroids, enzymes, supplements and central nervous system (CNS). The Company's brands include Anemi-XT for iron deficiency, Valcal-M for calcium deficiency, Gasease and IGTG FORTE for weak immunity. The Company's pharma unit is located at Solan, Himachal Pradesh; steel unit is located at Ropar, Punjab, and floriculture unit is located at Sirmour, Himachal Pradesh. The Company's subsidiary is Alchemist Healthcare Limited.

Sector

Diversified Chemicals

More about the company

Sector Diversified Chemicals

	1st Jan change	Capi.
ALCHEMIST LIMITED	-.--%	5L
SHIN-ETSU CHEMICAL CO., LTD.	+5.43%	7.71TCr
BASF SE	-7.37%	4.32TCr
DUPONT DE NEMOURS, INC.	+4.63%	3.37TCr
PIDILITE INDUSTRIES LIMITED	+16.35%	1.93TCr
EASTMAN CHEMICAL COMPANY	+9.07%	1.15TCr
SYENSQO SA/NV	-11.34%	942.18Cr
ASAHI KASEI CORPORATION	-0.82%	888Cr
SRF LIMITED	-1.92%	864.95Cr
MITSUBISHI CHEMICAL GROUP CORPORATION	+3.37%	789.79Cr

Diversified Chemicals